Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas?

@article{Varlotto2011ShouldLC,
  title={Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas?},
  author={John Michael Varlotto and Laura N. Medford-Davis and Abram R Recht and J C Flickinger and Eric Schaefer and Dani S. Zander and Malcolm M Decamp},
  journal={Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer},
  year={2011},
  volume={6 6},
  pages={
          1050-8
        }
}
BACKGROUND To compare the presenting and prognostic characteristics of patients with large cell neuroendocrine lung cancer (LCNELC) with those of patients with small cell lung cancer (SCLC) or other large cell carcinomas (OLCs) and to compare overall survival (OS) and lung cancer-specific survival (LCSS) rates for patients undergoing definitive resection without radiotherapy (S-NoRT). METHODS The Surveillance Epidemiology and End Results Database-17 from 2001 to 2007 was used. Differences… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 40 CITATIONS

The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.

  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2018
VIEW 11 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

The role of surgery in high grade neuroendocrine tumours of the lung.

  • Journal of thoracic disease
  • 2017
VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Lung Large Cell Neuroendocrine Carcinoma: An Analysis of Patients from the Surveillance, Epidemiology, and End-Results (SEER) Database

  • Medical science monitor : international medical journal of experimental and clinical research
  • 2019
VIEW 1 EXCERPT
CITES RESULTS

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.

  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2010
VIEW 1 EXCERPT

Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2010